Why BGPT?
logo

Review Papers Claim by Claim

Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.

Press Enter ↵ to start review


     Quick Explanation



    Zhu, Romero & Petty (2011) present a rigorously optimized WST-1/NADP+ cycling colorimetric assay for glucose-6-phosphate with an LOD of 0.15 µM, a linear range of 0.5–200 µM, and validated G6P measurement in deproteinized fetal bovine serum (6.2 ± 0.5 µM) . Verdict: a solid, practical analytical-methods contribution with credible validation, though validation breadth is narrow (one matrix) and %CV at the LLOQ (~13–16%) is modest.


     Long Explanation



    Core Evidence: Assay Design & Performance

    The assay couples G6PD (from Leuconostoc mesenteroides) oxidation of G6P to a NADP+/NADPH recycling reaction that reduces WST-1 to a water-soluble yellow formazan via 1-mPMS, read at 440 nm in 96-well format . The recycling design amplifies signal so NADP+ (25 µM) works far below the stoichiometric ~200 µM used in classic assays, driving LOD to 0.15 µM and LLOQ to 0.5 µM — a clear sensitivity gain over direct NADPH measurement at 339 nm . Specificity was tested against F6P, G1P, ribulose-5P, ribose-5P (all 100 µM) and glucose (100 mM); only ribulose-5P showed minimal interference.

    Validation in Serum: Genuine but Limited

    Calibration in deproteinized, heat-inactivated FBS gave a reproducible curve (slope 0.001169, n=8), spike recoveries of 91.4–92.2% at 30–60 µM spikes, and measured FBS G6P of 6.2 ± 0.5 µM, cross-checked against a conventional enzymatic assay (5.9 ± 0.3 µM) . This orthogonal agreement is the paper's strongest credibility signal. BGPT inference: the record's legacy extraction of "56.7–63.2% recovery" appears to confuse found (absolute) values with recovery percentages; the paper itself reports ~92% recovery, and the found-vs-expected values align.

    Precision and Blindspots

    At the LLOQ (0.5 µM), within-run and between-run %CV were 13.2% and 15.9% — within the 20% bioanalytical acceptance criterion but close to the margin, meaning low-end quantitation carries real uncertainty . Key blindspots: (1) only FBS was validated — human serum, hemolysates, and tissue extracts with endogenous G6PD or redox-active compounds were not tested, and 1-mPMS is redox-active so reducing agents in untested matrices could cause background; (2) ribulose-5P interference is acknowledged but not characterized quantitatively at low G6P levels; (3) ribulose-5P is itself a downstream product of the G6PD reaction, so coupled-pathway samples warrant caution; (4) no independent cross-lab reproducibility; (5) WST-8 substitution was mentioned but not validated because of kit-only availability — a vendor-dependent limitation. A 1997 PMS/MTS tetrazolium assay for the same metabolites already existed , so the novelty lies mainly in the WST-1/recycling 96-well implementation and serum validation rather than concept. The core claim is well supported; generalizability beyond FBS remains unproven. Confidence: moderate-high for reported performance; lower for broader applicability.

    Author Reviews:



    Feedback:    

    Updated: October 14, 2026

     BGPT Paper Review



    Study Novelty

    50%

    Incremental: tetrazolium-based NADP+-coupled dehydrogenase assays existed since 1997; the contribution is a better dye (WST-1), a recycling format in 96-well plates, and serum validation rather than a fundamentally new concept.



    Scientific Quality

    80%

    Systematic optimization of every reagent, formal LOD/LLOQ/precision/accuracy validation per bioanalytical standards, orthogonal cross-check with a conventional assay, and clear tables. Weaknesses: matrix validation limited to FBS, ribulose-5P interference not quantified, Excel ToolPak statistics.



    Study Generality

    70%

    A general-purpose analytical tool applicable to cells, tissues, and serum; demonstrated only in one matrix, but the method transfers conceptually to many biological settings.



    Study Usefulness

    80%

    Practical high-throughput assay requiring no autofluorescence correction, visible color readout, cheap reagents, and compatibility with clinical small samples — immediately useful for metabolic studies.



    Study Reproducibility

    90%

    Fully specified reagent concentrations, vendor catalog numbers, volumes, pH, timing, and statistical equations make independent replication straightforward; no data deposit, but the protocol is self-contained.



    Explanatory Depth

    70%

    Mechanistic recycling scheme is clearly articulated and supported by optimization data (pH, dye, mediator, NADP+, enzyme, time), but kinetic cycling efficiency and redox chemistry are not deeply characterized.


    🎁 Authors: Collect 282 Free Science Tokens (≈ $28.2 USD)

    Claim My Author Tokens

    Use for 70 days of free BGPT access (4 tokens = 1 day) or trade/sell (≈ $28.2 USD)

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    "Colorimetric assays cannot reach fluorimetric sensitivity" — falsified here: WST-1 recycling achieved an LOD comparable to the 2009 fluorimetric resorufin assay (0.15 vs 0.3 µM) while offering a wider linear range.


    "Direct NADPH absorbance at 339 nm is adequate for serum G6P" — rejected because the authors report NADPH's weak fluorescence/extinction and demonstrated that fluorescence failed on serum, motivating the colorimetric switch.

     Science Art


    Paper Review: An enzymatic colorimetric assay for glucose-6-phosphate Science Art

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT